Cancer

Researchers find new target for kidney cancer therapy

Cincinnati Cancer Center (CCC) researchers have discovered that a membrane channel, Transient Receptor Potential Melastatin 3, or TRPM3, promotes growth of kidney cancer tumors, and targeting this channel therapeutically ...

Nov 10, 2014
popularity 4.3 / 5 (4) | comments 0

Scientists solve mystery of 'Frankenstein' DNA

Australian researchers have uncovered how the massive DNA molecules that appear in some tumours are formed like Frankenstein's monster, stitched together from other parts of the genome. This solves a decades-old mystery and ...

Nov 10, 2014
popularity 5 / 5 (1) | comments 0

Nurse navigators may aid colon cancer screening follow-up

Group Health patients with a positive screening test for colon cancer (a stool test or sigmoidoscopy) tended to be more likely to get the recommended follow-up test, a diagnostic colonoscopy, if nurse navigators contacted ...

Nov 10, 2014
popularity not rated yet | comments 1

Equal care, survival rates for country cancer patients

Country South Australians with colorectal cancer that has spread to other areas of the body are receiving equal surgical care and have the same survival rates as those living in the city, according to new research from the ...

Nov 10, 2014
popularity not rated yet | comments 0

Latest Spotlight News

"Body recognition" compares with fingerprint ID

(Medical Xpress)—University of Adelaide forensic anatomy researchers are making advances in the use of "body recognition" for criminal and missing persons cases, to help with identification when a face ...

Stroke damage mechanism identified

Researchers have discovered a mechanism linked to the brain damage often suffered by stroke victims—and are now searching for drugs to block it.

Berberine compound may play role in treating obesity

(Medical Xpress)—Weight-gain warnings are especially uncomfortable during holiday seasons with all the oversized and double helpings of calorie-rich pies, creamy dips and savory holiday stuffings. Nonetheless, ...